摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲氧基苯磺酰氯 | 10130-87-7

中文名称
2-甲氧基苯磺酰氯
中文别名
——
英文名称
o-Methoxybenzenesulfonyl chloride
英文别名
2-methoxybenzenesulfonyl chloride
2-甲氧基苯磺酰氯化学式
CAS
10130-87-7
化学式
C7H7ClO3S
mdl
MFCD01961367
分子量
206.65
InChiKey
GYOBZOBUOMDRRN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    50-54°C
  • 沸点:
    126-129 °C(Press: 0.3 Torr)
  • 密度:
    1.376

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 危险等级:
    8
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R34
  • 危险品运输编号:
    UN 3261
  • 海关编码:
    2909309090
  • 包装等级:
  • 危险类别:
    IRRITANT
  • WGK Germany:
    3
  • 危险性防范说明:
    P260,P280,P303+P361+P353,P301+P330+P331,P304+P340+P310,P305+P351+P338+P310
  • 危险性描述:
    H314,H290
  • 储存条件:
    2-8°C

SDS

SDS:6a3ff80b42c0017b9a46a76195ec967b
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Methoxybenzenesulfonyl chloride
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H317: May cause an allergic skin reaction
P280: Wear protective gloves/protective clothing/eye protection/face protection

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxybenzenesulfonyl chloride
CAS number: 10130-87-7

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H7ClO3S
Molecular weight: 206.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN3261 Class: 8 Packing group: III
Proper shipping name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S. (2-Methoxybenzenesulfonyl chloride)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-甲氧基苯磺酰氯 作用下, 以 丙酮 为溶剂, 反应 0.03h, 生成 2-甲氧基苯磺酰胺
    参考文献:
    名称:
    解构非共价Kelch样ECH相关蛋白1(Keap1)抑制剂成碎片,以重建新的有效化合物。
    摘要:
    靶向核因子类红细胞2相关因子2(Nrf2)和与Kelch样ECH相关蛋白1(Keap1)之间的蛋白相互作用是控制涉及氧化应激疾病的潜在治疗策略。在这里,在基于片段的解构重建(FBDR)研究中,将六类已知的小分子Keap1-Nrf2 PPI抑制剂分解为77个片段,并在四个正交试验中进行了测试。这给出了17个片段命中,其中X射线晶体学显示其中6个在Keap1 Kelch结合袋中结合。相对于亲本片段,两个命中片段以220-380倍的亲和力(K i = 16μM)被合并到化合物8中。系统优化产生了一些与K i有关的新颖类似物值0.04–0.5μM,通过X射线晶体学测定的结合模式,以及增强的微粒体稳定性。这证明了FBDR如何可用于发现新的片段片段,阐明重要的配体-蛋白质相互作用以及鉴定Keap1-Nrf2 PPI的新有效抑制剂。
    DOI:
    10.1021/acs.jmedchem.0c02094
  • 作为产物:
    描述:
    邻甲氧基苯胺盐酸 、 sodium nitrite 、 二氧化硫 、 copper dichloride 作用下, 以 溶剂黄146 为溶剂, 以22%的产率得到2-甲氧基苯磺酰氯
    参考文献:
    名称:
    血小板活化因子(PAF)中的构效关系。11从PAF拮抗作用到磷脂酶A(2)抑制:1-芳基磺酰胺基-2-烷基哌嗪的合成与结构活性关系。
    摘要:
    1-苄基-2-烷基哌嗪是I和II组分泌的PLA(2)s的强抑制剂。通过用磺酰胺取代酰胺官能团并通过在苯磺酰基部分的对位引入电子给体取代基,可以提高其活性。哌嗪环的一个碳原子上的位置或该碳原子的绝对构型都不会影响对PLA(2)的一个或另一个基团的亲和力,但亲脂性对于这些系列仍然是必不可少的参数。此外,结构活性关系允许这些哌嗪衍生物与PLA(2)s催化位点相互作用的新假设。
    DOI:
    10.1016/s0223-5234(01)01274-0
点击查看最新优质反应信息

文献信息

  • Design and chemoproteomic functional characterization of a chemical probe targeted to bromodomains of BET family proteins
    作者:Jiang Wu、Julia Shin、Cara M. M. Williams、Kieran F. Geoghegan、Stephen W. Wright、David C. Limburg、Parag Sahasrabudhe、Paul D. Bonin、Bruce A. Lefker、Simeon J. Ramsey
    DOI:10.1039/c4md00259h
    日期:——

    Selectivity of a PFI-1 based BET bromodomain probe was demonstrated using affinity capture in nuclear extracts from human cells.

    使用亲和捕获在人类细胞核提取物中展示了基于PFI-1的BET溴结构域探针的选择性。
  • Phosphosulfonate herbicides
    申请人:Rohm and Haas Company
    公开号:US05500405A1
    公开(公告)日:1996-03-19
    This invention pertains to phosphosulfonates, having the general formula ##STR1## wherein Y is phenyl, naphthyl, benzyl, a (C.sub.5 -C.sub.8)cycloalkyl, a 5-membered heteroaromatic ring, a 6-membered heteraromatic ring, a fused 5,6-membered heteroaromatic ring, or a fused 6,6-membered heteroaromatic ring; and X is oxygen or sulfur; and R.sup.1 and R.sup.2 are each independently selected from substituted or unsubstituted alkyl, alkoxy, alkylthio, alkenyloxy, alkynyloxy, haloalkoxy, cyanoalkoxy, alkoxyalkoxy, cycloalkyloxy, cycloalkylalkoxy, alkylideneiminooxy, chloro, amino, phenyl or phenoxy; or R.sup.1 and R.sup.2 are both alkoxy, taken together with the phosphorus atom to form a 6-membered oxygen-containing ring; compositions containing these compounds and their use as herbicides.
    这项发明涉及磷磺酸酯,其一般公式为##STR1##其中Y为苯基、萘基、苄基、(C.sub.5 -C.sub.8)环烷基、5-成员杂芳环、6-成员杂芳环、融合的5,6-成员杂芳环或融合的6,6-成员杂芳环;X为氧或硫;R.sup.1和R.sup.2各自独立地选自取代或未取代的烷基、烷氧基、烷硫基、烯氧基、炔氧基、卤代烷氧基、氰基烷氧基、烷氧基烷氧基、环烷氧基、环烷基烷氧基、烷基亚胺氧基、氯、氨基、苯基或苯氧基;或R.sup.1和R.sup.2均为烷氧基,与磷原子一起形成一个6-成员含氧环;含有这些化合物的组合物及其用作除草剂。
  • [EN] SPIRO[CYCLOPENTANE-1,3'-INDOLIN]-2'-ONE DERIVATIVES AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS SPIRO[CYCLOPENTANE-1,3'-INDOLIN]-2'-ONE UTILISÉS EN TANT QU'INHIBITEURS DE BROMODOMAINES
    申请人:AURIGENE DISCOVERY TECH LTD
    公开号:WO2018109650A1
    公开(公告)日:2018-06-21
    The present invention provides spiro[cyclopentaneane-1,3'-indolin]-2'-one derivatives of formula (I), which are therapeutically useful, more particularly as bromodomain inhibitors. (I) wherein Cy, R1, R2, L and 'm' have the meaning given in the specification, and pharmaceutically acceptable salts or pharmaceutically acceptable stereoisomers thereof that are useful in the treatment and prevention of diseases or disorders, in particular their use as bromodomain inhibitors in the treatment and prevention of the associated diseases or disorders. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the spiro[cyclopentane-1,3'-indolin]-2'-one derivatives of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefore.
    本发明提供了式(I)的螺[环戊烷-1,3'-吲哚]-2'-酮衍生物,其在治疗上具有用途,更具体地作为溴结构域抑制剂。其中Cy、R1、R2、L和'm'在说明书中给出的含义,以及它们的药学上可接受的盐或药学上可接受的立体异构体,在治疗和预防疾病或紊乱方面具有用途,特别是它们作为溴结构域抑制剂在治疗和预防相关疾病或紊乱方面的用途。本发明还提供了该化合物的制备以及包括至少一种式(I)的螺[环戊烷-1,3'-吲哚]-2'-酮衍生物的药物配方,以及药学上可接受的载体、稀释剂或赋形剂。
  • BORON-CONTAINING SMALL MOLECULES
    申请人:Xia Yi
    公开号:US20100256092A1
    公开(公告)日:2010-10-07
    This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.
    这项发明涉及6-取代苯硼酯化合物等物品,以及它们用于治疗细菌感染的用途。
  • Application of a Catalytic Asymmetric Povarov Reaction using Chiral Ureas to the Synthesis of a Tetrahydroquinoline Library
    作者:Baudouin Gerard、Morgan Welzel O’Shea、Etienne Donckele、Sarathy Kesavan、Lakshmi B. Akella、Hao Xu、Eric N. Jacobsen、Lisa A. Marcaurelle
    DOI:10.1021/co300098v
    日期:2012.11.12
    A 2328-membered library of 2,3,4-trisubstituted tetrahydroquinolines was produced using a combination of solution- and solid-phase synthesis techniques. A tetrahydroquinoline (THQ) scaffold was prepared via an asymmetric Povarov reaction using cooperative catalysis to generate three contiguous stereogenic centers. A matrix of 4 stereoisomers of the THQ scaffold was prepared to enable the development
    使用溶液和固相合成技术的组合,生成了2328元的2,3,4-三取代四氢喹啉文库。四氢喹啉(THQ)支架是通过不对称的Povarov反应使用协同催化制备的,以产生三个连续的立体中心。制备了THQ支架的4种立体异构体矩阵,以通过生物学测试建立立体/结构-活性关系(SSAR)。稀疏矩阵设计策略用于选择要合成的文库成员,目的是生成具有适合下游发现的理化性质的四氢喹啉类化合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐